"NCTNumber"	"Title"	"country"	"ISO2"	"latitude"	"longitude"
"NCT02735707"	"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia"	"Australia"	"AU"	-25.274398	133.775136
"NCT03042143"	"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19)"	"UK"	"GB"	55.378051	-3.435973
"NCT03331445"	"Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections"	"Canada"	"CA"	56.130366	-106.346771
"NCT03680274"	"Lessening Organ Dysfunction With VITamin C"	"Canada"	"CA"	56.130366	-106.346771
"NCT03808922"	"Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study"	"USA"	"US"	37.09024	-95.712891
"NCT03891420"	"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04061382"	"Sero-epidemiological Survey of England in 2019/2020"	"UK"	"GB"	55.378051	-3.435973
"NCT04244591"	"Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure"	"China"	"CN"	35.86166	104.195397
"NCT04245631"	"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV"	"China"	"CN"	35.86166	104.195397
"NCT04251767"	"Washed Microbiota Transplantation for Patients With 2019-nCoV Infection"	"China"	"CN"	35.86166	104.195397
"NCT04251871"	"Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection"	"China"	"CN"	35.86166	104.195397
"NCT04252118"	"Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04252274"	"Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04252664"	"A Trial of Remdesivir in Adults With Mild and Moderate COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04254874"	"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04255017"	"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04255940"	"2019-nCoV Outbreak and Cardiovascular Diseases"	"China"	"CN"	35.86166	104.195397
"NCT04256395"	"Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04257656"	"A Trial of Remdesivir in Adults With Severe COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04259892"	"Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection"	"France"	"FR"	46.227638	2.213749
"NCT04260308"	"A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04261270"	"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04261517"	"Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04262921"	"Clinical Characterisation Protocol for Severe Emerging Infections"	"France"	"FR"	46.227638	2.213749
"NCT04263402"	"The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04264533"	"Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04264858"	"Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients"	"China"	"CN"	35.86166	104.195397
"NCT04269525"	"Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04270383"	"Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children"	"China"	"CN"	35.86166	104.195397
"NCT04272710"	"Prognositc Factors in COVID-19 Patients Complicated With Hypertension"	"China"	"CN"	35.86166	104.195397
"NCT04273321"	"Efficacy and Safety of Corticosteroids in COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04273646"	"Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04273763"	"Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)"	"China"	"CN"	35.86166	104.195397
"NCT04274322"	"Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool"	"China"	"CN"	35.86166	104.195397
"NCT04275245"	"Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04275414"	"Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04275414"	"Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia"	"Italy"	"IT"	41.87194	12.56738
"NCT04275947"	"The COVID-19 Mobile Health Study (CMHS)"	"China"	"CN"	35.86166	104.195397
"NCT04276896"	"Immunity and Safety of Covid-19 Synthetic Minigene Vaccine"	"China"	"CN"	35.86166	104.195397
"NCT04278963"	"Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04279197"	"Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu"	"China"	"CN"	35.86166	104.195397
"NCT04279782"	"Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection"	"China"	"CN"	35.86166	104.195397
"NCT04279795"	"Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations"	"China"	"CN"	35.86166	104.195397
"NCT04279899"	"The Investigation of the Neonates With or With Risk of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04280224"	"NK Cells Treatment for COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04280588"	"Fingolimod in COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04280705"	"Adaptive COVID-19 Treatment Trial (ACTT)"	"USA"	"US"	37.09024	-95.712891
"NCT04280913"	"Clinical Outcomes of Patients With COVID19"	"China"	"CN"	35.86166	104.195397
"NCT04281693"	"A New Screening Strategy for 2019 Novel Coronavirus Infection"	"China"	"CN"	35.86166	104.195397
"NCT04283461"	"Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04284046"	"CT Scores Predict Mortality in 2019-nCoV Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04287686"	"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04288102"	"Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19)"	"China"	"CN"	35.86166	104.195397
"NCT04290780"	"COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus"	"France"	"FR"	46.227638	2.213749
"NCT04291729"	"Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection"	"China"	"CN"	35.86166	104.195397
"NCT04292327"	"Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus"	"China"	"CN"	35.86166	104.195397
"NCT04292340"	"Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04292730"	"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734<U+0099>) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment"	"USA"	"US"	37.09024	-95.712891
"NCT04292899"	"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734<U+0099>) in Participants With Severe Coronavirus Disease (COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04292964"	"Prognostic Factors of Patients With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04293692"	"Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus"	"China"	"CN"	35.86166	104.195397
"NCT04298060"	"DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)"	"China"	"CN"	35.86166	104.195397
"NCT04299724"	"Safety and Immunity of Covid-19 aAPC Vaccine"	"China"	"CN"	35.86166	104.195397
"NCT04302688"	"Accurate Classification System for Patients With COVID-19 Pneumonitis"	"China"	"CN"	35.86166	104.195397
"NCT04303299"	"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial"	"Thailand"	"TH"	15.870032	100.992541
"NCT04304053"	"Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention"	"Spain"	"ES"	40.463667	-3.74922
"NCT04304313"	"A Pilot Study of Sildenafil in COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04304690"	"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic"	"France"	"FR"	46.227638	2.213749
"NCT04305106"	"Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT"	"China"	"CN"	35.86166	104.195397
"NCT04305457"	"Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04305574"	"Social Media Use During COVID-19"	"Singapore"	"SG"	1.352083	103.819836
"NCT04306055"	"Blood Donor Recruitment During Epidemic of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04306393"	"Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04306497"	"Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19."	"China"	"CN"	35.86166	104.195397
"NCT04306705"	"Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04307459"	"Acute Respiratory Failure and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Real Life"	"Italy"	"IT"	41.87194	12.56738
"NCT04307693"	"Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)"	"South Korea"	"KR"	35.907757	127.766922
"NCT04308187"	"Influence of the COvid-19 Epidemic on STRESS"	"France"	"FR"	46.227638	2.213749
"NCT04308317"	"Tetrandrine Tablets Used in the Treatment of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04308668"	"Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2"	"USA"	"US"	37.09024	-95.712891
"NCT04308668"	"Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2"	"Canada"	"CA"	56.130366	-106.346771
"NCT04310228"	"Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019"	"China"	"CN"	35.86166	104.195397
"NCT04310865"	"Yinhu Qingwen Granula for the Treatment of Severe CoVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04311177"	"Losartan for Patients With COVID-19 Not Requiring Hospitalization"	"USA"	"US"	37.09024	-95.712891
"NCT04311398"	"Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System"	"China"	"CN"	35.86166	104.195397
"NCT04311697"	"Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress"	"USA"	"US"	37.09024	-95.712891
"NCT04311697"	"Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress"	"Israel"	"IL"	31.046051	34.851612
"NCT04312009"	"Losartan for Patients With COVID-19 Requiring Hospitalization"	"USA"	"US"	37.09024	-95.712891
"NCT04312100"	"Sequential Oxygen Therapy Strategy for Patients With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04312464"	"Myocardial Damage in COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04313127"	"Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults"	"China"	"CN"	35.86166	104.195397
"NCT04313322"	"Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells"	"Jordan"	"JO"	30.585164	36.238414
"NCT04313946"	"Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays"	"Italy"	"IT"	41.87194	12.56738
"NCT04313946"	"Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays"	"Romania"	"RO"	45.943161	24.96676
"NCT04313946"	"Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays"	"UK"	"GB"	55.378051	-3.435973
"NCT04315298"	"Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04315480"	"Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis"	"Italy"	"IT"	41.87194	12.56738
"NCT04315870"	"Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy."	"Italy"	"IT"	41.87194	12.56738
"NCT04315896"	"Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04315948"	"Trial of Treatments for COVID-19 in Hospitalized Adults"	"France"	"FR"	46.227638	2.213749
"NCT04315987"	"NestCell<U+00AE> Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04316299"	"Acute Kidney Injury in Patients Hospitalized With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04316377"	"Norwegian Coronavirus Disease 2019 Study"	"Norway"	"NO"	60.472024	8.468946
"NCT04316728"	"Clinical Performance of the VivaDiag <U+0099> COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19"	"Italy"	"IT"	41.87194	12.56738
"NCT04316884"	"Mechanisms for Organ Dysfunction in Covid-19"	"Sweden"	"SE"	60.128161	18.643501
"NCT04316949"	"Predictors of Respiratory Failure in SARS-Cov-2 Infection"	"Italy"	"IT"	41.87194	12.56738
"NCT04317040"	"CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment"	"USA"	"US"	37.09024	-95.712891
"NCT04317092"	"Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)"	"Italy"	"IT"	41.87194	12.56738
"NCT04318015"	"Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04318301"	"Hypertension in Patients Hospitalized With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04318314"	"COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2"	"UK"	"GB"	55.378051	-3.435973
"NCT04318366"	"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor"	"Italy"	"IT"	41.87194	12.56738
"NCT04318418"	"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19"	"Italy"	"IT"	41.87194	12.56738
"NCT04318431"	"Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children"	"France"	"FR"	46.227638	2.213749
"NCT04318444"	"Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04319016"	"Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy"	"Italy"	"IT"	41.87194	12.56738
"NCT04319211"	"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress"	"Turkey"	"TR"	38.963745	35.243322
"NCT04319315"	"Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak"	"Egypt"	"EG"	26.820553	30.802498
"NCT04319445"	"Mindfulness During COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04319731"	"A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure"	"USA"	"US"	37.09024	-95.712891
"NCT04320017"	"Joint Use of Electrocardiogram and Transthoracic Echocardiography in an Observational Study to Monitor Cardio-vascular Events in Patients Diagnosed With COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04320238"	"Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff"	"China"	"CN"	35.86166	104.195397
"NCT04320277"	"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study."	"Italy"	"IT"	41.87194	12.56738
"NCT04320472"	"Acute Encephalopathy in Critically Ill Patients With COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04320511"	"Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2"	"USA"	"US"	37.09024	-95.712891
"NCT04320615"	"A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia"	"USA"	"US"	37.09024	-95.712891
"NCT04320732"	"Risk Factors for Community- and Workplace Transmission of COVID-19"	"Norway"	"NO"	60.472024	8.468946
"NCT04320862"	"COVID-19 Pandemic Response Network"	"USA"	"US"	37.09024	-95.712891
"NCT04320953"	"Non-contact Endoscopy at Covid-19 Outbreak"	"China"	"CN"	35.86166	104.195397
"NCT04321096"	"The Impact of Camostat Mesilate on COVID-19 Infection"	"Denmark"	"DK"	56.26392	9.501785
"NCT04321174"	"COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir"	"Canada"	"CA"	56.130366	-106.346771
"NCT04321265"	"Outcomes and Prognostic Factors in COVID-19"	"Denmark"	"DK"	56.26392	9.501785
"NCT04321265"	"Outcomes and Prognostic Factors in COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04321265"	"Outcomes and Prognostic Factors in COVID-19"	"Germany"	"DE"	51.165691	10.451526
"NCT04321278"	"Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04321369"	"Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals"	"USA"	"US"	37.09024	-95.712891
"NCT04321421"	"Hyperimmune Plasma for Critical Patients With COVID-19"	"Italy"	"IT"	41.87194	12.56738
"NCT04321616"	"The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients"	"Norway"	"NO"	60.472024	8.468946
"NCT04321811"	"Behavior, Environment And Treatments for Covid-19"	"USA"	"US"	37.09024	-95.712891
"NCT04321993"	"Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients"	"Canada"	"CA"	56.130366	-106.346771
"NCT04322123"	"Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus (COVID-19)"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04322188"	"An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection"	"Italy"	"IT"	41.87194	12.56738
"NCT04322279"	"Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO)"	"France"	"FR"	46.227638	2.213749
"NCT04322344"	"Escin in Patients With Covid-19 Infection"	"Italy"	"IT"	41.87194	12.56738
"NCT04322396"	"Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19"	"Denmark"	"DK"	56.26392	9.501785
"NCT04322487"	"Simple, Safe, Same: Lung Ultrasound for COVID-19"	"Italy"	"IT"	41.87194	12.56738
"NCT04322513"	"Biomarkers for Identification of COVID-19 Infection"	"Italy"	"IT"	41.87194	12.56738
"NCT04322682"	"Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)"	"USA"	"US"	37.09024	-95.712891
"NCT04322682"	"Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)"	"Canada"	"CA"	56.130366	-106.346771
"NCT04322773"	"Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure"	"Denmark"	"DK"	56.26392	9.501785
"NCT04323332"	"Traditional Chinese Medicine for Severe COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04323345"	"Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus"	"Egypt"	"EG"	26.820553	30.802498
"NCT04323514"	"Use of Ascorbic Acid in Patients With COVID 19"	"Italy"	"IT"	41.87194	12.56738
"NCT04323527"	"Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04323592"	"Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome"	"Italy"	"IT"	41.87194	12.56738
"NCT04323761"	"Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04323787"	"Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry"	"USA"	"US"	37.09024	-95.712891
"NCT04323839"	"COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)"	"USA"	"US"	37.09024	-95.712891
"NCT04324021"	"Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection."	"Italy"	"IT"	41.87194	12.56738
"NCT04324047"	"Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients"	"France"	"FR"	46.227638	2.213749
"NCT04324073"	"Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI"	"France"	"FR"	46.227638	2.213749
"NCT04324190"	"DIgital Online SuPport for COVID-19 StrEss"	"Germany"	"DE"	51.165691	10.451526
"NCT04324463"	"Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial"	"Canada"	"CA"	56.130366	-106.346771
"NCT04324489"	"DAS181 for Severe COVID-19: Compassionate Use"	"China"	"CN"	35.86166	104.195397
"NCT04324528"	"Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation"	"Germany"	"DE"	51.165691	10.451526
"NCT04324606"	"A Study of a Candidate COVID-19 Vaccine (COV001)"	"UK"	"GB"	55.378051	-3.435973
"NCT04324684"	"Prognostic Factors Keeping Track for Covid-19 Pneumonia"	"Italy"	"IT"	41.87194	12.56738
"NCT04324736"	"COVID-19 and Diabetes Outcomes"	"France"	"FR"	46.227638	2.213749
"NCT04324996"	"A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04325061"	"Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19"	"Spain"	"ES"	40.463667	-3.74922
"NCT04325412"	"Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY"	"Netherlands"	"NL"	52.132633	5.291266
"NCT04325646"	"Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples"	"France"	"FR"	46.227638	2.213749
"NCT04325867"	"Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19"	"Romania"	"RO"	45.943161	24.96676
"NCT04325893"	"Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease"	"France"	"FR"	46.227638	2.213749
"NCT04325906"	"Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS"	"USA"	"US"	37.09024	-95.712891
"NCT04326036"	"Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04326309"	"Audio Data Collection for Identification and Classification of Coughing"	"USA"	"US"	37.09024	-95.712891
"NCT04326387"	"Evaluation of Novel Diagnostic Tests for COVID-19"	"UK"	"GB"	55.378051	-3.435973
"NCT04326426"	"ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04326452"	"Treating COVID-19 With a Bidirectional Oxygenation Valve"	"USA"	"US"	37.09024	-95.712891
"NCT04326725"	"Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia"	"Turkey"	"TR"	38.963745	35.243322
"NCT04326920"	"Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)"	"Belgium"	"BE"	50.503887	4.469936
"NCT04327180"	"PREdiction of DIagnosed Covid-19 infecTion in IUC Patients"	"France"	"FR"	46.227638	2.213749
"NCT04327206"	"BCG Vaccination to Protect Healthcare Workers Against COVID-19"	"Australia"	"AU"	-25.274398	133.775136
"NCT04327349"	"Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial"	"Iran"	"IR"	32.427908	53.688046
"NCT04327388"	"Sarilumab COVID-19"	"Canada"	"CA"	56.130366	-106.346771
"NCT04327388"	"Sarilumab COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04327401"	"COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04327479"	"Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection"	"Germany"	"DE"	51.165691	10.451526
"NCT04327531"	"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study"	"Turkey"	"TR"	38.963745	35.243322
"NCT04327674"	"The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19"	"Denmark"	"DK"	56.26392	9.501785
"NCT04327804"	"A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research"	"USA"	"US"	37.09024	-95.712891
"NCT04328012"	"COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2"	"USA"	"US"	37.09024	-95.712891
"NCT04328129"	"Household Transmission Investigation Study for COVID-19 in French Guiana"	"French Guiana"	"GF"	3.933889	-53.125782
"NCT04328272"	"Effectiveness of Hydroxychloroquine in Covid-19 Patients"	"Pakistan"	"PK"	30.375321	69.345116
"NCT04328285"	"Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers"	"France"	"FR"	46.227638	2.213749
"NCT04328441"	"Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine"	"Netherlands"	"NL"	52.132633	5.291266
"NCT04328454"	"Clinical Characteristics and Prognostic Factors of Patients With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04328467"	"Pre-exposure Prophylaxis for SARS-Coronavirus-2"	"USA"	"US"	37.09024	-95.712891
"NCT04328493"	"The Vietnam Chloroquine Treatment on COVID-19"	"Vietnam"	"VN"	14.058324	108.277199
"NCT04328961"	"Hydroxychloroquine for COVID-19 PEP"	"USA"	"US"	37.09024	-95.712891
"NCT04329195"	"ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic"	"France"	"FR"	46.227638	2.213749
"NCT04329546"	"Understanding COVID-19"	"Switzerland"	"CH"	46.818188	8.227512
"NCT04329559"	"COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study"	"China"	"CN"	35.86166	104.195397
"NCT04329611"	"ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease"	"Canada"	"CA"	56.130366	-106.346771
"NCT04329650"	"Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia"	"Spain"	"ES"	40.463667	-3.74922
"NCT04329832"	"Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04329897"	"Acceptance and Commitment Therapy Delivered by Automated Software Messaging"	"USA"	"US"	37.09024	-95.712891
"NCT04329923"	"The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)"	"USA"	"US"	37.09024	-95.712891
"NCT04330261"	"Clinical Characteristics and Outcomes of Pediatric COVID-19"	"Canada"	"CA"	56.130366	-106.346771
"NCT04330300"	"Coronavirus (COVID-19) ACEi/ARB Investigation"	"Ireland"	"IE"	53.41291	-8.24389
"NCT04330638"	"Treatment of COVID-19 Patients With Anti-interleukin Drugs"	"Belgium"	"BE"	50.503887	4.469936
"NCT04330690"	"Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial"	"Canada"	"CA"	56.130366	-106.346771
"NCT04331054"	"Protective Role of Inhaled Steroids for Covid-19 Infection"	"France"	"FR"	46.227638	2.213749
"NCT04331106"	"Survey of the Anxiety Associated With the COVID-19 Pandemic"	"Germany"	"DE"	51.165691	10.451526
"NCT04331171"	"Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage"	"France"	"FR"	46.227638	2.213749
"NCT04331366"	"Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04331470"	"Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19"	"Iran"	"IR"	32.427908	53.688046
"NCT04331509"	"COVID-19 Symptom Tracker"	"USA"	"US"	37.09024	-95.712891
"NCT04331509"	"COVID-19 Symptom Tracker"	"UK"	"GB"	55.378051	-3.435973
"NCT04331574"	"Renin-Angiotensin System Inhibitors and COVID-19"	"Italy"	"IT"	41.87194	12.56738
"NCT04331613"	"Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS"	"China"	"CN"	35.86166	104.195397
"NCT04331665"	"Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia"	"Canada"	"CA"	56.130366	-106.346771
"NCT04331795"	"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis"	"USA"	"US"	37.09024	-95.712891
"NCT04331834"	"Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic"	"Spain"	"ES"	40.463667	-3.74922
"NCT04331886"	"An Observational Study of Patients With Coronavirus Disease 2019"	"USA"	"US"	37.09024	-95.712891
"NCT04332016"	"COVID-19 Biological Samples Collection"	"France"	"FR"	46.227638	2.213749
"NCT04332042"	"TOFAcitinib in SARS-CoV2 Pneumonia"	"Italy"	"IT"	41.87194	12.56738
"NCT04332081"	"Hyperbaric Oxygen for COVID-19 Patients"	"USA"	"US"	37.09024	-95.712891
"NCT04332094"	"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19"	"Spain"	"ES"	40.463667	-3.74922
"NCT04332107"	"Azithromycin for COVID-19 Treatment in Outpatients Nationwide"	"USA"	"US"	37.09024	-95.712891
"NCT04332380"	"Convalescent Plasma for Patients With COVID-19: A Pilot Study"	"Colombia"	"CO"	4.570868	-74.297333
"NCT04332835"	"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study"	"Colombia"	"CO"	4.570868	-74.297333
"NCT04332913"	"Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia"	"Italy"	"IT"	41.87194	12.56738
"NCT04332991"	"Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease"	"USA"	"US"	37.09024	-95.712891
"NCT04333225"	"Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers"	"USA"	"US"	37.09024	-95.712891
"NCT04333355"	"Safety in Convalescent Plasma Transfusion to COVID-19"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04333368"	"Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS"	"France"	"FR"	46.227638	2.213749
"NCT04333407"	"Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial."	"UK"	"GB"	55.378051	-3.435973
"NCT04333420"	"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia"	"Netherlands"	"NL"	52.132633	5.291266
"NCT04333472"	"Piclidenoson for Treatment of COVID-19"	"Israel"	"IL"	31.046051	34.851612
"NCT04333550"	"Application of Desferal to Treat COVID-19"	"Iran"	"IR"	32.427908	53.688046
"NCT04333589"	"Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive"	"China"	"CN"	35.86166	104.195397
"NCT04333654"	"Hydroxychloroquine in Outpatient Adults With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04333654"	"Hydroxychloroquine in Outpatient Adults With COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04333693"	"Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study"	"Spain"	"ES"	40.463667	-3.74922
"NCT04333732"	"CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION"	"USA"	"US"	37.09024	-95.712891
"NCT04333732"	"CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION"	"Australia"	"AU"	-25.274398	133.775136
"NCT04333732"	"CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION"	"Canada"	"CA"	56.130366	-106.346771
"NCT04333732"	"CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION"	"Ireland"	"IE"	53.41291	-8.24389
"NCT04333849"	"Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04333862"	"Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy"	"Switzerland"	"CH"	46.818188	8.227512
"NCT04333875"	"Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis"	"Switzerland"	"CH"	46.818188	8.227512
"NCT04333914"	"Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection"	"France"	"FR"	46.227638	2.213749
"NCT04333953"	"COVID-19 in Patients With HIV"	"USA"	"US"	37.09024	-95.712891
"NCT04334005"	"Vitamin D on Prevention and Treatment of COVID-19"	"Spain"	"ES"	40.463667	-3.74922
"NCT04334044"	"Treatment of SARS Caused by COVID-19 With Ruxolitinib"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04334265"	"Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019"	"China"	"CN"	35.86166	104.195397
"NCT04334291"	"International COVID19 Clinical Evaluation Registry,"	"Spain"	"ES"	40.463667	-3.74922
"NCT04334382"	"Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04334434"	"Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19)"	"Turkey"	"TR"	38.963745	35.243322
"NCT04334512"	"A Study of Quintuple Therapy to Treat COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04334850"	"Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia"	"France"	"FR"	46.227638	2.213749
"NCT04334928"	"Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel"	"Spain"	"ES"	40.463667	-3.74922
"NCT04334954"	"SARS-COV2 Pandemic Serosurvey and Blood Sampling"	"USA"	"US"	37.09024	-95.712891
"NCT04334967"	"Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care"	"USA"	"US"	37.09024	-95.712891
"NCT04334980"	"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19"	"Canada"	"CA"	56.130366	-106.346771
"NCT04335071"	"Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)"	"Switzerland"	"CH"	46.818188	8.227512
"NCT04335084"	"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04335123"	"Study of Open Label Losartan in COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04335136"	"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19"	"Austria"	"AT"	47.516231	14.550072
"NCT04335136"	"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19"	"Denmark"	"DK"	56.26392	9.501785
"NCT04335162"	"Cardiovascular Complications and COVID-19 (CovCardioVasc)"	"France"	"FR"	46.227638	2.213749
"NCT04335188"	"COVID-19 Registry Rhineland-Palatinate (Germany)"	"Germany"	"DE"	51.165691	10.451526
"NCT04335305"	"Checkpoint Blockade in COVID-19 Pandemic"	"Spain"	"ES"	40.463667	-3.74922
"NCT04335552"	"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04335630"	"Cardiovascular Manifestations of COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04335747"	"COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases"	"Denmark"	"DK"	56.26392	9.501785
"NCT04335773"	"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology"	"Norway"	"NO"	60.472024	8.468946
"NCT04335786"	"Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease"	"Netherlands"	"NL"	52.132633	5.291266
"NCT04335851"	"Video-Based Exercises and Well-Being During Social Isolation"	"Turkey"	"TR"	38.963745	35.243322
"NCT04336215"	"Rutgers COVID-19 Cohort Study"	"USA"	"US"	37.09024	-95.712891
"NCT04336254"	"Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients"	"China"	"CN"	35.86166	104.195397
"NCT04336332"	"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04336345"	"Outcomes of Patients With COVID-19 in the Intensive Care Unit"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04336384"	"Impact of Covid-19 in Congenital Heart Disease"	"France"	"FR"	46.227638	2.213749
"NCT04336410"	"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers"	"USA"	"US"	37.09024	-95.712891
"NCT04336462"	"Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04336657"	"Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?"	"Egypt"	"EG"	26.820553	30.802498
"NCT04336761"	"Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France"	"France"	"FR"	46.227638	2.213749
"NCT04336774"	"CAPTION AI to Minimize Risk of COVID Exposure"	"USA"	"US"	37.09024	-95.712891
"NCT04336787"	"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine"	"Turkey"	"TR"	38.963745	35.243322
"NCT04336904"	"Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19"	"Italy"	"IT"	41.87194	12.56738
"NCT04336956"	"Covid-19 Pediatric Observatory"	"France"	"FR"	46.227638	2.213749
"NCT04337008"	"Renin Angiotesnin System - CoronaVirus"	"France"	"FR"	46.227638	2.213749
"NCT04337047"	"Assessment of Distress in Crisis Situations During COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04337151"	"Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment"	"UK"	"GB"	55.378051	-3.435973
"NCT04337190"	"Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)"	"France"	"FR"	46.227638	2.213749
"NCT04337320"	"Evaluation of Postnatal Outcomes of Covid 19 Positive Mothers Newborns"	"Turkey"	"TR"	38.963745	35.243322
"NCT04337346"	"Evaluation of Covid 19 Anxiety in Endometriosis Patients"	"Turkey"	"TR"	38.963745	35.243322
"NCT04337502"	"Clinical and Radiomic Model of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04337541"	"Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System"	"Denmark"	"DK"	56.26392	9.501785
"NCT04337762"	"Beat COVID-19 - Observational Trial"	"USA"	"US"	37.09024	-95.712891
"NCT04337983"	"Hemodynamic Characteristics of Patients With SARS-CoV-2"	"France"	"FR"	46.227638	2.213749
"NCT04338074"	"TXA and Corona Virus 2019 (COVID19) in Outpatients"	"USA"	"US"	37.09024	-95.712891
"NCT04338126"	"Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients"	"USA"	"US"	37.09024	-95.712891
"NCT04338347"	"CAP-1002 in Severe COVID-19 Disease"	"USA"	"US"	37.09024	-95.712891
"NCT04338360"	"Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04338568"	"Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study"	"Belgium"	"BE"	50.503887	4.469936
"NCT04338672"	"The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients"	"Israel"	"IL"	31.046051	34.851612
"NCT04338828"	"Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED"	"USA"	"US"	37.09024	-95.712891
"NCT04338841"	"HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection"	"Belgium"	"BE"	50.503887	4.469936
"NCT04338841"	"HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection"	"France"	"FR"	46.227638	2.213749
"NCT04338945"	"Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy"	"Italy"	"IT"	41.87194	12.56738
"NCT04338958"	"Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation"	"Germany"	"DE"	51.165691	10.451526
"NCT04339387"	"COVID-19 Risk Stratification"	"USA"	"US"	37.09024	-95.712891
"NCT04339608"	"Max COVID19- Study"	"India"	"IN"	20.593684	78.96288
"NCT04339634"	"Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy"	"USA"	"US"	37.09024	-95.712891
"NCT04339660"	"Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia"	"China"	"CN"	35.86166	104.195397
"NCT04339712"	"Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction"	"Greece"	"GR"	39.074208	21.824312
"NCT04339790"	"Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers"	"USA"	"US"	37.09024	-95.712891
"NCT04339842"	"Eating Habits of Adults During the Quarantine"	"Cyprus"	"CY"	35.126413	33.429859
"NCT04339998"	"Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)"	"USA"	"US"	37.09024	-95.712891
"NCT04340050"	"COVID-19 Convalescent Plasma"	"USA"	"US"	37.09024	-95.712891
"NCT04340219"	"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic"	"Belgium"	"BE"	50.503887	4.469936
"NCT04340232"	"Safety and Efficacy of Baricitinib for COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04340349"	"Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04340414"	"Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP"	"China"	"CN"	35.86166	104.195397
"NCT04340466"	"French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study"	"France"	"FR"	46.227638	2.213749
"NCT04340479"	"The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation"	"USA"	"US"	37.09024	-95.712891
"NCT04340544"	"Hydroxychloroquine for the Treatment of Mild COVID-19 Disease"	"Germany"	"DE"	51.165691	10.451526
"NCT04340557"	"Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04341012"	"Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases"	"USA"	"US"	37.09024	-95.712891
"NCT04341038"	"Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury"	"Spain"	"ES"	40.463667	-3.74922
"NCT04341116"	"Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04341142"	"Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER"	"France"	"FR"	46.227638	2.213749
"NCT04341168"	"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults"	"Germany"	"DE"	51.165691	10.451526
"NCT04341207"	"Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients"	"France"	"FR"	46.227638	2.213749
"NCT04341285"	"Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID)"	"Germany"	"DE"	51.165691	10.451526
"NCT04341389"	"A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)"	"China"	"CN"	35.86166	104.195397
"NCT04341415"	"Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome"	"France"	"FR"	46.227638	2.213749
"NCT04341441"	"Will Hydroxychloroquine Impede or Prevent COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04341480"	"The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04341493"	"Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04341519"	"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers"	"France"	"FR"	46.227638	2.213749
"NCT04341610"	"ASC Therapy for Patients With Severe Respiratory COVID-19"	"Denmark"	"DK"	56.26392	9.501785
"NCT04341675"	"Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia"	"USA"	"US"	37.09024	-95.712891
"NCT04341714"	"Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic"	"France"	"FR"	46.227638	2.213749
"NCT04341727"	"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04341766"	"Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19"	"France"	"FR"	46.227638	2.213749
"NCT04341870"	"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO"	"France"	"FR"	46.227638	2.213749
"NCT04341922"	"A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic"	"Sweden"	"SE"	60.128161	18.643501
"NCT04341935"	"Effects of DPP4 Inhibition on COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04342104"	"NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure"	"Spain"	"ES"	40.463667	-3.74922
"NCT04342169"	"University of Utah COVID-19 Hydrochloroquine Trial"	"USA"	"US"	37.09024	-95.712891
"NCT04342182"	"Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)"	"Netherlands"	"NL"	52.132633	5.291266
"NCT04342195"	"Acquiring Convalescent Specimens for COVID-19 Antibodies"	"USA"	"US"	37.09024	-95.712891
"NCT04342221"	"Hydroxychloroquine for COVID-19"	"Germany"	"DE"	51.165691	10.451526
"NCT04342637"	"COVID-19 Endoscopy Survey"	"USA"	"US"	37.09024	-95.712891
"NCT04342637"	"COVID-19 Endoscopy Survey"	"Egypt"	"EG"	26.820553	30.802498
"NCT04342637"	"COVID-19 Endoscopy Survey"	"Iran"	"IR"	32.427908	53.688046
"NCT04342650"	"Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04342663"	"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04342702"	"A Study on the Prospective Cohort Library of COVID-19 in Southeran"	"China"	"CN"	35.86166	104.195397
"NCT04342728"	"Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation"	"USA"	"US"	37.09024	-95.712891
"NCT04342806"	"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04342884"	"COVID-19 Community Research Partnership"	"USA"	"US"	37.09024	-95.712891
"NCT04343001"	"Coronavirus Response - Active Support for Hospitalised Covid-19 Patients"	"Nigeria"	"NG"	9.081999	8.675277
"NCT04343001"	"Coronavirus Response - Active Support for Hospitalised Covid-19 Patients"	"Pakistan"	"PK"	30.375321	69.345116
"NCT04343053"	"Pro-thrombotic Status in Patients With SARS-Cov-2 Infection"	"Italy"	"IT"	41.87194	12.56738
"NCT04343144"	"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo<U+00AE>) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort."	"France"	"FR"	46.227638	2.213749
"NCT04343183"	"Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04343261"	"Convalescent Plasma in the Treatment of COVID 19"	"USA"	"US"	37.09024	-95.712891
"NCT04343339"	"Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment"	"France"	"FR"	46.227638	2.213749
"NCT04343404"	"PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2"	"France"	"FR"	46.227638	2.213749
"NCT04343651"	"Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04343664"	"Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia"	"Indonesia"	"ID"	-0.789275	113.921327
"NCT04343677"	"Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study"	"USA"	"US"	37.09024	-95.712891
"NCT04343690"	"COPING With COVID-19( CWC-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04343729"	"Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04343742"	"Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19"	"Colombia"	"CO"	4.570868	-74.297333
"NCT04343755"	"Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04343768"	"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial"	"Iran"	"IR"	32.427908	53.688046
"NCT04343781"	"National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04343898"	"Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04343963"	"Pyridostigmine in Severe SARS-CoV-2 Infection"	"Mexico"	"MX"	23.634501	-102.552784
"NCT04343976"	"Pegylated Interferon Lambda Treatment for COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04343989"	"A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04344002"	"LunG canceR pAtients coVId19 Disease (GRAVID)"	"Spain"	"ES"	40.463667	-3.74922
"NCT04344015"	"COVID-19 Plasma Collection"	"USA"	"US"	37.09024	-95.712891
"NCT04344041"	"COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)"	"France"	"FR"	46.227638	2.213749
"NCT04344080"	"Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19"	"Germany"	"DE"	51.165691	10.451526
"NCT04344106"	"Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study"	"France"	"FR"	46.227638	2.213749
"NCT04344119"	"Assessment of Chilbains Occuring During Covid-19 Infection"	"France"	"FR"	46.227638	2.213749
"NCT04344145"	"Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population"	"Belgium"	"BE"	50.503887	4.469936
"NCT04344171"	"CovidDB: The Covid-19 Inpatient Database"	"Germany"	"DE"	51.165691	10.451526
"NCT04344171"	"CovidDB: The Covid-19 Inpatient Database"	"Romania"	"RO"	45.943161	24.96676
"NCT04344184"	"Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI)"	"USA"	"US"	37.09024	-95.712891
"NCT04344197"	"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey"	"Italy"	"IT"	41.87194	12.56738
"NCT04344210"	"Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04344236"	"Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04344249"	"Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic"	"France"	"FR"	46.227638	2.213749
"NCT04344288"	"Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection"	"France"	"FR"	46.227638	2.213749
"NCT04344327"	"COVID-19 in Cardiology Unit in France : Risk Factors for Mortality (CCF)"	"France"	"FR"	46.227638	2.213749
"NCT04344379"	"Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus"	"France"	"FR"	46.227638	2.213749
"NCT04344431"	"Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)"	"France"	"FR"	46.227638	2.213749
"NCT04344444"	"Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease"	"USA"	"US"	37.09024	-95.712891
"NCT04344457"	"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04344535"	"Convalescent Plasma vs. Standard Plasma for COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04344548"	"Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia"	"Colombia"	"CO"	4.570868	-74.297333
"NCT04344600"	"Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 Infection"	"USA"	"US"	37.09024	-95.712891
"NCT04344730"	"Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia"	"France"	"FR"	46.227638	2.213749
"NCT04344756"	"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort"	"France"	"FR"	46.227638	2.213749
"NCT04344912"	"Impact of COVID19 Outbreak in Cardiac Acute Care"	"France"	"FR"	46.227638	2.213749
"NCT04344951"	"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial"	"Greece"	"GR"	39.074208	21.824312
"NCT04345159"	"Prevalence of COVID-19 Symptoms History in Patients With Autoimmune Diseases"	"France"	"FR"	46.227638	2.213749
"NCT04345276"	"Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection"	"China"	"CN"	35.86166	104.195397
"NCT04345289"	"Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia"	"Denmark"	"DK"	56.26392	9.501785
"NCT04345315"	"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent."	"Italy"	"IT"	41.87194	12.56738
"NCT04345406"	"Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04345419"	"A Real-life Experience on Treatment of Patients With COVID 19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04345445"	"Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression"	"Malaysia"	"MY"	4.210484	101.975766
"NCT04345523"	"Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients"	"Spain"	"ES"	40.463667	-3.74922
"NCT04345536"	"Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital"	"Norway"	"NO"	60.472024	8.468946
"NCT04345549"	"Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak"	"UK"	"GB"	55.378051	-3.435973
"NCT04345601"	"Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)"	"USA"	"US"	37.09024	-95.712891
"NCT04345614"	"A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia"	"USA"	"US"	37.09024	-95.712891
"NCT04345640"	"The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver."	"India"	"IN"	20.593684	78.96288
"NCT04345653"	"Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers"	"USA"	"US"	37.09024	-95.712891
"NCT04345692"	"A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients"	"USA"	"US"	37.09024	-95.712891
"NCT04345848"	"Preventing COVID-19 Complications With Low- and High-dose Anticoagulation"	"Switzerland"	"CH"	46.818188	8.227512
"NCT04345861"	"Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)"	"France"	"FR"	46.227638	2.213749
"NCT04345887"	"Spironolactone in Covid-19 Induced ARDS"	"Turkey"	"TR"	38.963745	35.243322
"NCT04345991"	"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort"	"France"	"FR"	46.227638	2.213749
"NCT04346017"	"Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome"	"Belgium"	"BE"	50.503887	4.469936
"NCT04346043"	"To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database"	"Egypt"	"EG"	26.820553	30.802498
"NCT04346056"	"Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04346147"	"Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19"	"Spain"	"ES"	40.463667	-3.74922
"NCT04346160"	"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease"	"Italy"	"IT"	41.87194	12.56738
"NCT04346186"	"COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff"	"Denmark"	"DK"	56.26392	9.501785
"NCT04346199"	"Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. CALAVI (Calquence Against the Virus)"	"Spain"	"ES"	40.463667	-3.74922
"NCT04346212"	"Oropharyngeal Dysphagia in Patients With COVID-19"	"Spain"	"ES"	40.463667	-3.74922
"NCT04346264"	"CoVid-19 - Infection and Antibody Formation in the Viennese Population"	"Austria"	"AT"	47.516231	14.550072
"NCT04346277"	"Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)"	"Italy"	"IT"	41.87194	12.56738
"NCT04346329"	"Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19"	"Colombia"	"CO"	4.570868	-74.297333
"NCT04346342"	"PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID)"	"Netherlands"	"NL"	52.132633	5.291266
"NCT04346355"	"Efficacy of Early Administration of Tocilizumab in COVID-19 Patients"	"Italy"	"IT"	41.87194	12.56738
"NCT04346368"	"Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)"	"China"	"CN"	35.86166	104.195397
"NCT04346420"	"Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19"	"Belgium"	"BE"	50.503887	4.469936
"NCT04346446"	"Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients"	"India"	"IN"	20.593684	78.96288
"NCT04346589"	"Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients"	"Italy"	"IT"	41.87194	12.56738
"NCT04346628"	"Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04346693"	"An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19"	"Russia"	"RU"	61.52401	105.318756
"NCT04347031"	"An Open Randomized Study of the Effectiveness of Mefloquine for the Treatment of Patients With COVID19"	"Russia"	"RU"	61.52401	105.318756
"NCT04347070"	"Implementation of Physiotherapy on COVID-19 Patients in ICU"	"France"	"FR"	46.227638	2.213749
"NCT04347174"	"A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients"	"India"	"IN"	20.593684	78.96288
"NCT04347226"	"Anti-Interleukin-8 (Anti-IL-8) for Cancer Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04347239"	"Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04347369"	"A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease"	"China"	"CN"	35.86166	104.195397
"NCT04347382"	"Efficacy of Nigella Sativa and Natural Honey Against COVID-19: an RCT"	"Pakistan"	"PK"	30.375321	69.345116
"NCT04347408"	"Rapid Diagnostics, Antibody Testing and Host Response in Children With COVID-19"	"UK"	"GB"	55.378051	-3.435973
"NCT04347460"	"Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH"	"Germany"	"DE"	51.165691	10.451526
"NCT04347538"	"Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04347681"	"Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19"	"Saudi Arabia"	"SA"	23.885942	45.079162
"NCT04347798"	"IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT"	"Canada"	"CA"	56.130366	-106.346771
"NCT04347824"	"Predict Adverse Events by Covid-19 Nephritis"	"Germany"	"DE"	51.165691	10.451526
"NCT04347850"	"A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19)"	"France"	"FR"	46.227638	2.213749
"NCT04347876"	"Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?"	"Egypt"	"EG"	26.820553	30.802498
"NCT04347941"	"Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE"	"Ireland"	"IE"	53.41291	-8.24389
"NCT04347954"	"PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)"	"USA"	"US"	37.09024	-95.712891
"NCT04347980"	"Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19"	"France"	"FR"	46.227638	2.213749
"NCT04347993"	"""A Prospective """"Universal"""" Observational Database for COVID-19"""	"USA"	"US"	37.09024	-95.712891
"NCT04348214"	"Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals"	"Egypt"	"EG"	26.820553	30.802498
"NCT04348227"	"How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?"	"Tunisia"	"TN"	33.886917	9.537499
"NCT04348240"	"Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions"	"USA"	"US"	37.09024	-95.712891
"NCT04348370"	"BCG Vaccine for Health Care Workers as Defense Against SARS-COV2"	"USA"	"US"	37.09024	-95.712891
"NCT04348383"	"Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19."	"Spain"	"ES"	40.463667	-3.74922
"NCT04348396"	"Clinical and Biological Predictors of COVID-19 Disease in Older Patients"	"Italy"	"IT"	41.87194	12.56738
"NCT04348409"	"Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04348435"	"Study of Allogeneic HB-adMSCs to Provide Immune Support Against COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04348474"	"Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04348513"	"Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection"	"Greece"	"GR"	39.074208	21.824312
"NCT04348656"	"CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)"	"Canada"	"CA"	56.130366	-106.346771
"NCT04348695"	"Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19."	"Spain"	"ES"	40.463667	-3.74922
"NCT04348864"	"COVID-19 Antibody Self-testing Using Virtual Point-of-care"	"USA"	"US"	37.09024	-95.712891
"NCT04348877"	"Plasma Rich Antibodies From Recovered Patients From COVID19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04348929"	"Birth Experience During COVID-19 Confinement"	"France"	"FR"	46.227638	2.213749
"NCT04349202"	"Beaumont Health Large-scale Automated Serologic Testing for COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04349228"	"Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals"	"Tunisia"	"TN"	33.886917	9.537499
"NCT04349241"	"Efficacy and Safety of Favipiravir in Management of COVID-19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04349371"	"Saved From COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04349410"	"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol"	"USA"	"US"	37.09024	-95.712891
"NCT04349540"	"Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19"	"UK"	"GB"	55.378051	-3.435973
"NCT04349618"	"Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia"	"France"	"FR"	46.227638	2.213749
"NCT04349631"	"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04349982"	"ICU Trial in Critical Ill COVID-19 Patients"	"Austria"	"AT"	47.516231	14.550072
"NCT04350073"	"Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)"	"USA"	"US"	37.09024	-95.712891
"NCT04350086"	"Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection"	"France"	"FR"	46.227638	2.213749
"NCT04350099"	"Emotional Burden of Healthcare Professionals and Covid Infection 19"	"France"	"FR"	46.227638	2.213749
"NCT04350450"	"Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore"	"USA"	"US"	37.09024	-95.712891
"NCT04350476"	"COVID-19 Remote Monitoring"	"USA"	"US"	37.09024	-95.712891
"NCT04350593"	"Dapagliflozin in Respiratory Failure in Patients With COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04350671"	"Interferon Beta 1a in Hospitalized COVID-19 Patients"	"Iran"	"IR"	32.427908	53.688046
"NCT04350684"	"Umifenovir in Hospitalized COVID-19 Patients"	"Iran"	"IR"	32.427908	53.688046
"NCT04350710"	"Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS"	"France"	"FR"	46.227638	2.213749
"NCT04350736"	"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19"	"UK"	"GB"	55.378051	-3.435973
"NCT04350931"	"Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04351139"	"Impact of the COVID-19 Pandemic in Gynecological Oncology"	"France"	"FR"	46.227638	2.213749
"NCT04351295"	"Efficacy of Faviprevir in COVID-19 Treatment"	"Egypt"	"EG"	26.820553	30.802498
"NCT04351347"	"The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment"	"Egypt"	"EG"	26.820553	30.802498
"NCT04351503"	"A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City"	"Switzerland"	"CH"	46.818188	8.227512
"NCT04351516"	"Test and Treat COVID 65plus+"	"Germany"	"DE"	51.165691	10.451526
"NCT04351529"	"Austrian COVID-19 Registry"	"Austria"	"AT"	47.516231	14.550072
"NCT04351542"	"Ayurveda for Flu Like Illness During Covid-19 Outbreak"	"UK"	"GB"	55.378051	-3.435973
"NCT04351581"	"Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19"	"Denmark"	"DK"	56.26392	9.501785
"NCT04351620"	"High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19"	"USA"	"US"	37.09024	-95.712891
"NCT04351646"	"Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak)"	"UK"	"GB"	55.378051	-3.435973
"NCT04351659"	"Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19"	"Singapore"	"SG"	1.352083	103.819836
"NCT04351711"	"Immunological Profiling of Patients With COVID-19 in Respiratory Distress"	"France"	"FR"	46.227638	2.213749
"NCT04351724"	"Austrian CoronaVirus Adaptive Clinical Trial"	"Austria"	"AT"	47.516231	14.550072
"NCT04351763"	"Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms"	"Poland"	"PL"	51.919438	19.145136
"NCT04351854"	"Registry for Clinical Presentation and Management of Patients With Coronavirus Disease 2019 in the Emergency Room"	"Germany"	"DE"	51.165691	10.451526
"NCT04351906"	"Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome"	"Germany"	"DE"	51.165691	10.451526
"NCT04351919"	"Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)"	"Tunisia"	"TN"	33.886917	9.537499
"NCT04352348"	"Cohort of Patients Infected With SARS-CoV2 ou Suspected of Being"	"France"	"FR"	46.227638	2.213749
"NCT04352491"	"An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease"	"India"	"IN"	20.593684	78.96288
"NCT04352517"	"Influence Physical Activity Psychological Responses COVID-19 Pandemic"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04352517"	"Influence Physical Activity Psychological Responses COVID-19 Pandemic"	"Chile"	"CL"	-35.675147	-71.542969
"NCT04352517"	"Influence Physical Activity Psychological Responses COVID-19 Pandemic"	"Uruguay"	"UY"	-32.522779	-55.765835
"NCT04352556"	"COVID19-hematological Malignancies: the Italian Hematology Alliance"	"Italy"	"IT"	41.87194	12.56738
"NCT04352582"	"COVID-19 and Vaccination Attitudes"	"UK"	"GB"	55.378051	-3.435973
"NCT04352608"	"Safety and Immunogenicity Study of 2019-nCoV Vaccine (Inactivated) for Prophylaxis SARS CoV-2 Infection (COVID-19)"	"China"	"CN"	35.86166	104.195397
"NCT04352634"	"The Covid-19 HEalth caRe wOrkErS (HEROES) Study"	"USA"	"US"	37.09024	-95.712891
"NCT04352634"	"The Covid-19 HEalth caRe wOrkErS (HEROES) Study"	"Chile"	"CL"	-35.675147	-71.542969
"NCT04352634"	"The Covid-19 HEalth caRe wOrkErS (HEROES) Study"	"Italy"	"IT"	41.87194	12.56738
"NCT04352634"	"The Covid-19 HEalth caRe wOrkErS (HEROES) Study"	"Spain"	"ES"	40.463667	-3.74922
"NCT04352699"	"Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?"	"France"	"FR"	46.227638	2.213749
"NCT04352751"	"Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020"	"Pakistan"	"PK"	30.375321	69.345116
"NCT04352764"	"Use of the ANTIBODY BASED LATERAL FLOW IMMUNOASSAY TESTS FOR SARSCoV-2 THAT CAUSES CORONAVIRUS DISEASE 2019 (COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings"	"USA"	"US"	37.09024	-95.712891
"NCT04352842"	"Echocardiographic Manifestation in Patient With COVID-19"	"China"	"CN"	35.86166	104.195397
"NCT04352946"	"HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial"	"USA"	"US"	37.09024	-95.712891
"NCT04353037"	"PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine"	"USA"	"US"	37.09024	-95.712891
"NCT04353141"	"International Lung UltraSound Analysis (ILUSA) Study"	"Belgium"	"BE"	50.503887	4.469936
"NCT04353141"	"International Lung UltraSound Analysis (ILUSA) Study"	"Italy"	"IT"	41.87194	12.56738
"NCT04353180"	"Assessment the Activity Value of Retinoic Acid in the Treatment of COVID-19"	"Egypt"	"EG"	26.820553	30.802498
"NCT04353206"	"Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure"	"USA"	"US"	37.09024	-95.712891
"NCT04353245"	"Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System"	"Brazil"	"BR"	-14.235004	-51.92528
"NCT04353271"	"Trial of Hydroxychloroquine In Covid-19 Kinetics"	"USA"	"US"	37.09024	-95.712891
"NCT04353323"	"COVID 19-Caregivers IGg Seroconversion"	"France"	"FR"	46.227638	2.213749
"NCT04353336"	"Efficacay of Chloroquine in COVID-19 Treatment"	"Egypt"	"EG"	26.820553	30.802498
"NCT04353401"	"WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS"	"USA"	"US"	37.09024	-95.712891
"NCT04353583"	"Renal Outcome in Patients With COVID-19"	"Germany"	"DE"	51.165691	10.451526
"NCT04353596"	"Stopping ACE-inhibitors in COVID-19"	"Austria"	"AT"	47.516231	14.550072
